209 related articles for article (PubMed ID: 24296879)
1. Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate.
Maund SL; Nolley R; Peehl DM
Lab Invest; 2014 Feb; 94(2):208-21. PubMed ID: 24296879
[TBL] [Abstract][Full Text] [Related]
2. Tissue slice grafts: an in vivo model of human prostate androgen signaling.
Zhao H; Nolley R; Chen Z; Peehl DM
Am J Pathol; 2010 Jul; 177(1):229-39. PubMed ID: 20472887
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.
McPherson SJ; Hussain S; Balanathan P; Hedwards SL; Niranjan B; Grant M; Chandrasiri UP; Toivanen R; Wang Y; Taylor RA; Risbridger GP
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3123-8. PubMed ID: 20133657
[TBL] [Abstract][Full Text] [Related]
4. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
5. Functional Organotypic Cultures of Prostate Tissues: A Relevant Preclinical Model that Preserves Hypoxia Sensitivity and Calcium Signaling.
Figiel S; Pasqualin C; Bery F; Maupoil V; Vandier C; Potier-Cartereau M; Domingo I; Guibon R; Bruyere F; Maheo K; Fromont G
Am J Pathol; 2019 Jun; 189(6):1268-1275. PubMed ID: 30954471
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture.
Planz B; Kirley SD; Wang Q; Tabatabaei S; Aretz HT; McDougal WS
J Urol; 1999 Apr; 161(4):1329-36. PubMed ID: 10081903
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.
Keshari KR; Sriram R; Van Criekinge M; Wilson DM; Wang ZJ; Vigneron DB; Peehl DM; Kurhanewicz J
Prostate; 2013 Aug; 73(11):1171-81. PubMed ID: 23532911
[TBL] [Abstract][Full Text] [Related]
8. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.
Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U
Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108
[TBL] [Abstract][Full Text] [Related]
9. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
Gannon PO; Godin-Ethier J; Hassler M; Delvoye N; Aversa M; Poisson AO; Péant B; Alam Fahmy M; Saad F; Lapointe R; Mes-Masson AM
PLoS One; 2010 Aug; 5(8):e12107. PubMed ID: 20711410
[TBL] [Abstract][Full Text] [Related]
10. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
Chen R; Yu Y; Dong X
J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
[TBL] [Abstract][Full Text] [Related]
12. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
13. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
Lin TH; Lee SO; Niu Y; Xu D; Liang L; Li L; Yeh SD; Fujimoto N; Yeh S; Chang C
J Biol Chem; 2013 Jul; 288(27):19359-69. PubMed ID: 23687298
[TBL] [Abstract][Full Text] [Related]
14. A novel tissue-slice culture model for non-malignant human prostate.
Bläuer M; Tammela TL; Ylikomi T
Cell Tissue Res; 2008 Jun; 332(3):489-98. PubMed ID: 18386065
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
16. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
17. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
18. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
19. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
Bello D; Webber MM; Kleinman HK; Wartinger DD; Rhim JS
Carcinogenesis; 1997 Jun; 18(6):1215-23. PubMed ID: 9214605
[TBL] [Abstract][Full Text] [Related]
20. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
